Glycinamide derivatives as raf-kinase inhibitors

Details for Australian Patent Application No. 2003250197 (hide)

Owner Merck Patent GmbH

Inventors Zenke, Frank; Sirrenberg, Christian; Schadt, Oliver; Buchstaller, Hans-Peter; Grell, Matthias; Wiesner, Matthias; Amendt, Christiane

Agent Davies Collison Cave

Pub. Number AU-B-2003250197

PCT Number PCT/EP03/08474

PCT Pub. Number WO2004/019941

Priority 02019023.7 27.08.02 EP

Filing date 31 July 2003

Wipo publication date 19 March 2004

Acceptance publication date 12 November 2009

International Classifications

C07D 213/64 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 31/4439 (2006.01)

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 213/65 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/68 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/807 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Event Publications

16 October 2003 Complete Application Filed

  Priority application(s): 02019023.7 27.08.02 EP

6 May 2004 Application Open to Public Inspection

  Published as AU-B-2003250197

12 November 2009 Application Accepted

  Published as AU-B-2003250197

11 March 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003250198-QUANTITATIVE MULTIPLEX AMPLIFICACTION ON A GENOMIC SCALE, AND APPLICATIONS FOR DETECTING GENOMIC REARRANGEMENTS

2003250196-METHOD FOR PREPARING OLIGONUCLEOTIDES